Compare BFLY & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BFLY | IART |
|---|---|---|
| Founded | 2011 | 1989 |
| Country | United States | United States |
| Employees | 220 | N/A |
| Industry | Medical Electronics | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 823.8M |
| IPO Year | N/A | 1996 |
| Metric | BFLY | IART |
|---|---|---|
| Price | $4.68 | $10.46 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | $5.00 | ★ $14.33 |
| AVG Volume (30 Days) | ★ 5.0M | 684.9K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.01 | $4.39 |
| Revenue Next Year | $19.93 | $3.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.32 | $8.70 |
| 52 Week High | $5.72 | $16.42 |
| Indicator | BFLY | IART |
|---|---|---|
| Relative Strength Index (RSI) | 50.14 | 52.31 |
| Support Level | $3.71 | $8.79 |
| Resistance Level | $5.00 | $11.57 |
| Average True Range (ATR) | 0.37 | 0.59 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 40.30 | 42.42 |
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.